Insider Matthew Paul Del Giudice Buys 50,000 Shares of MIRA
Matthew Paul Del Giudice has increased his holdings in MIRA with a 50,000 share purchase.
Key Points
- Matthew Paul Del Giudice bought 50,000 shares of MIRA on June 12, 2026, showing confidence in the company.
- MIRA's stock is trading around $0.93 with significant insider buying activity.
- Institutional investors like Vanguard Capital Management and BlackRock also adjusted their MIRA holdings recently.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 12, 2026, insider Matthew Paul Del Giudice purchased 50,000 shares of MIRA. This move suggests a vote of confidence in the company, as the stock trades around $0.93.
Insider Buying and Selling at MIRA Pharmaceuticals, Inc.
Several insiders, including Matthew Paul Del Giudice, bought 50,000 shares each of MIRA on June 12, 2026. Other insiders such as Edward Clouston Macpherson, Matthew Pratt Whalen, and Denil Nanji Shekhat also made similar purchases on the same day. Erez Aminov, CEO and Chairman, had previously acquired over 3.15 million shares on December 17, 2025.
Other Institutional Activity in MIRA
In recent activity, Vanguard Capital Management LLC significantly increased its position by adding 693,912 shares, bringing its total to 693,912 shares valued at about $742,486. Geode Capital Management, LLC also expanded its holdings by 18,012 shares, ending with 290,890 shares worth approximately $311,251. Meanwhile, BlackRock, Inc. added 2,577 shares, for a total of 112,346 shares valued at $120,210. However, Suncoast Equity Management reduced its stake by 12,644 shares, now holding 90,645 shares valued at $96,990.
MIRA Pharmaceuticals, Inc. Stock Up 24.2%
Shares of MIRA are trading near $0.93. The stock has seen various institutional activities, reflecting diverse investor strategies. Despite the lack of current earnings or dividend data, the insider and institutional movements indicate ongoing interest in the stock.
Bottom Line
The recent insider buying activity at MIRA, especially by Matthew Paul Del Giudice and other key figures, indicates confidence in the company's prospects. With the stock trading at about $0.93, investors are closely watching these transactions. Institutional investors have also made notable moves, adding to the dynamic picture of MIRA's ownership landscape.
Get MIRA Pharmaceuticals, Inc. alerts
New 13F filings, insider trades, and analyst moves on $MIRA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.